| 1 |
35072253 | Metformin in selected malignancies in women. | 2022 Jan 24 |
1 |
| 2 |
35550195 | Metformin-induced downregulation of c-Met is a determinant of sensitivity in MDA-MB-468 breast cancer cells. | 2022 Jul 12 |
1 |
| 3 |
32674107 | Combination of LMT-28 and Metformin Improves Beneficial Anti-Inflammatory Effect in Collagen-Induced Arthritis. | 2021 |
1 |
| 4 |
32791889 | Metformin Reduces Thyroid Cancer Tumor Growth in the Metastatic Niche of Bone by Inhibiting Osteoblastic RANKL Productions. | 2021 May |
1 |
| 5 |
33262823 | Metformin inhibits epithelial-mesenchymal transition of oral squamous cell carcinoma via the mTOR/HIF-1α/PKM2/STAT3 pathway. | 2021 Jan |
2 |
| 6 |
33603170 | Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling. | 2021 Mar |
1 |
| 7 |
34154617 | Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts. | 2021 Jun 21 |
1 |
| 8 |
34238029 | Metformin Antagonizes Ovarian Cancer Cells Malignancy Through MSLN Mediated IL-6/STAT3 Signaling. | 2021 Jan-Dec |
3 |
| 9 |
34302119 | Correction: Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling. | 2021 Aug |
1 |
| 10 |
34881181 | Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Catrcinoma by Inhibiting IL-6 Signaling Pathway. | 2021 |
2 |
| 11 |
34887262 | Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3. | 2021 Dec |
1 |
| 12 |
32258099 | Metformin's Effects on Apoptosis of Esophageal Carcinoma Cells and Normal Esophageal Epithelial Cells: An In Vitro Comparative Study. | 2020 |
2 |
| 13 |
32460059 | Metformin suppresses the growth of leukemia cells partly through downregulation of AXL receptor tyrosine kinase. | 2020 Jul |
1 |
| 14 |
32470453 | The impact of metformin and aspirin on T-cell mediated inflammation: A systematic review of in vitro and in vivo findings. | 2020 Aug 15 |
1 |
| 15 |
33116117 | Metformin as a senostatic drug enhances the anticancer efficacy of CDK4/6 inhibitor in head and neck squamous cell carcinoma. | 2020 Oct 28 |
2 |
| 16 |
33126079 | Activation of AMPK suppresses S1P-induced airway smooth muscle cells proliferation and its potential mechanisms. | 2020 Dec |
1 |
| 17 |
33149616 | Metformin Combined with 4SC-202 Inhibited the Migration and Invasion of OSCC via STAT3/TWIST1. | 2020 |
3 |
| 18 |
30019648 | Metformin one in a Million Efficient Medicines for Rheumatoid Arthritis Complications: Inflammation, Osteoblastogenesis, Cardiovascular Disease, Malignancies. | 2019 |
1 |
| 19 |
31154939 | Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease. | 2019 Aug 2 |
1 |
| 20 |
31278880 | Effects of metformin and phenformin on apoptosis and epithelial-mesenchymal transition in chemoresistant rectal cancer. | 2019 Sep |
1 |
| 21 |
31337349 | Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways. | 2019 Jul 23 |
2 |
| 22 |
29472557 | Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms. | 2018 Feb 22 |
1 |
| 23 |
28011481 | Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB. | 2017 Jan |
1 |
| 24 |
28030813 | Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation. | 2017 Jan 31 |
7 |
| 25 |
28043910 | Metformin inhibits castration-induced EMT in prostate cancer by repressing COX2/PGE2/STAT3 axis. | 2017 Mar 28 |
3 |
| 26 |
28114390 | High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer. | 2017 |
5 |
| 27 |
28345832 | Metformin Inhibits Migration and Invasion of Cholangiocarcinoma Cells | 2017 Feb 1 |
2 |
| 28 |
28445726 | Sirtuin-1 Activation Controls Tumor Growth by Impeding Th17 Differentiation via STAT3 Deacetylation. | 2017 Apr 25 |
1 |
| 29 |
28823275 | [Effect of Metformin on Proliferation of Multiple Myeloma Cells]. | 2017 Aug |
1 |
| 30 |
28837141 | Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT. | 2017 Aug 24 |
5 |
| 31 |
28964970 | Metformin triggers apoptosis in PEL cells and alters bortezomib-induced Unfolded Protein Response increasing its cytotoxicity and inhibiting KSHV lytic cycle activation. | 2017 Dec |
1 |
| 32 |
29073599 | Combination of Solamargine and Metformin Strengthens IGFBP1 Gene Expression Through Inactivation of Stat3 and Reciprocal Interaction Between FOXO3a and SP1. | 2017 |
1 |
| 33 |
29088816 | Metformin inhibits esophageal squamous cell carcinoma-induced angiogenesis by suppressing JAK/STAT3 signaling pathway. | 2017 Sep 26 |
2 |
| 34 |
27126953 | Metformin attenuates graft-versus-host disease via restricting mammalian target of rapamycin/signal transducer and activator of transcription 3 and promoting adenosine monophosphate-activated protein kinase-autophagy for the balance between T helper 17 and Tregs. | 2016 Jul |
3 |
| 35 |
27919027 | Phosphorylation of Janus kinase 1 (JAK1) by AMP-activated protein kinase (AMPK) links energy sensing to anti-inflammatory signaling. | 2016 Nov 8 |
1 |
| 36 |
25370454 | Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma. | 2015 Jun 1 |
1 |
| 37 |
25462562 | Metformin enhances the anti-adipogenic effects of atorvastatin via modulation of STAT3 and TGF-β/Smad3 signaling. | 2015 Jan 2 |
1 |
| 38 |
26056043 | Metformin combined with aspirin significantly inhibit pancreatic cancer cell growth in vitro and in vivo by suppressing anti-apoptotic proteins Mcl-1 and Bcl-2. | 2015 Aug 28 |
1 |
| 39 |
26360050 | Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance. | 2015 |
3 |
| 40 |
26641266 | Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages. | 2015 |
1 |
| 41 |
24302004 | Suppression of the mTORC1/STAT3/Notch1 pathway by activated AMPK prevents hepatic insulin resistance induced by excess amino acids. | 2014 Jan 15 |
2 |
| 42 |
24322659 | Metformin selectively targets tumor-initiating cells in ErbB2-overexpressing breast cancer models. | 2014 Feb |
1 |
| 43 |
24577086 | Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling. | 2014 Feb 27 |
7 |
| 44 |
23277563 | Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth. | 2013 Jan 15 |
1 |
| 45 |
23526220 | Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway. | 2013 Aug |
5 |
| 46 |
22189713 | Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers. | 2012 Jan 15 |
10 |
| 47 |
23162655 | Metformin inhibits leptin-induced growth and migration of glioblastoma cells. | 2012 Nov |
2 |
| 48 |
21776823 | Antidiabetic drug metformin induces apoptosis in human MCF breast cancer via targeting ERK signaling. | 2011 |
2 |
| 49 |
15236798 | AMPK activation may suppress hepatic production of C-reactive protein by stimulating nitric oxide synthase. | 2004 |
1 |